90015-82-0 Usage
General Description
The chemical named ((2R,3S,5R)-5-(5-(3-Aminopropyl)-2,4-dinoxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate, also known as hATP, is a complex organic molecule. It has elements of carbon, hydrogen, nitrogen, oxygen, and phosphorus in its structure. ((2R,3S,5R)-5-(5-(3-Aminopropyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate can be classified under the Nucleoside Triphosphates chemical category, hence, is likely to be involved in biological reactions pertaining to nucleic acids synthesis, such as DNA replication and repair or RNA synthesis. The chemical structure contains a dihydropyrimidinyl group which is linked to a hydroxytetrahydrofuran. The 'amino-propyl' extension likely increases its molecular flexibility, whereas the triphosphate group provides the potential for high-energy bonds, making it a possible part of ATP-related biochemical processes. Further studies are needed for its comprehensive understanding.
Check Digit Verification of cas no
The CAS Registry Mumber 90015-82-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,0,1 and 5 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 90015-82:
(7*9)+(6*0)+(5*0)+(4*1)+(3*5)+(2*8)+(1*2)=100
100 % 10 = 0
So 90015-82-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H22N3O14P3/c13-3-1-2-7-5-15(12(18)14-11(7)17)10-4-8(16)9(27-10)6-26-31(22,23)29-32(24,25)28-30(19,20)21/h5,8-10,16H,1-4,6,13H2,(H,22,23)(H,24,25)(H,14,17,18)(H2,19,20,21)/t8-,9-,10-/m1/s1
90015-82-0Relevant articles and documents
A SYSTEM FOR DELIVERING THERAPEUTIC AGENTS INTO LIVING CELLS AND CELL NUCLEI
-
Page/Page column 70-72, (2008/06/13)
A novel class of oligomeric compounds designed for forming conjugates with biologically active substances and delivering these substances to a desired bodily target are disclosed. Nove1 conjugates of biologically active moities and such oligomeric compounds, pharmaceutical compositions containing such conjugates, and uses thereof as delivery systems for delivering the biologically active substances to a desired target are further disclosed. Processes of preparing the conjugates and the oligomeric compounds and novel intermediates designed for and used in these processes are also disclosed.